查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494619

基因組測試市場：按組件、技術、應用、分銷管道、最終用途分類 - 2024-2030 年全球預測

Genome Testing Market by Component (Consumables, Equipment, Software & Services), Technology (Microarrays, Next-Generation Sequencing, Targeted Sequencing), Application, Distribution Channel, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年基因組檢測市場規模為175.7億美元，預計2024年將達到197.6億美元，2030年將達419億美元，複合年成長率為13.21%。

基因組測試通常稱為全基因組定序 (WGS)，涉及一次性檢查生物體基因組中 DNA 的完整序列。這種全面的分析涵蓋了所有類型的遺傳變異，包括插入、缺失、單核苷酸多態性 (SNP)、拷貝數變異和大的結構變化。人們對早期疾病檢測和預防的日益關注，以及對血統和系譜日益成長的興趣，也增加了基因組測試的重要性。然而，與基因組設備相關的高成本和解釋遺傳訊息的複雜性正在影響市場成長。此外，人工智慧和巨量資料分析的結合以改善遺傳資料的解釋，正在為市場成長創造潛在機會。

主要市場統計
基準年[2023] 175.7億美元
預計年份 [2024] 197.6億美元
預測年份 [2030] 419億美元
複合年成長率（%） 13.21%

區域洞察

在美洲，特別是在美國和加拿大，個人化醫療意識的增強以及對預防性醫療保健的興趣日益濃厚，正在推動消費者對基因組檢測的需求。在高可支配收入和大量醫療保健支出的推動下，這些地區的客戶表現出投資健康和保健的意願。遺傳疾病的日益普及正在推動對基因組檢測服務的需求。由於成員國之間醫療保健系統、法規和消費者態度的差異，歐盟 (EU) 為基因組檢測提供了多元化的市場。隱私權問題、道德考量以及一般資料保護規範 (GDPR) 等法規結構對客戶的購買行為有重大影響。中東和非洲新興國家對基因組檢測的需求程度不同。在中東，每個國家都擁有發達的醫療保健系統，人們對個人化醫療的基因組測試的興趣與日俱增。亞太地區基因組檢測市場正在迅速開拓，特別是在中國、日本和印度。中國對生物技術的投資正在迅速增加，大型基因組研究計劃和國際合作就是證明。

FPNV定位矩陣

FPNV定位矩陣對於評估基因組檢測市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對基因組測試市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該領域競爭性質的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在基因組測試市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球遺傳疾病和癌症的發生率正在增加
      • 疾病的早​​期發現和預防變得越來越重要
      • 個人化醫療意識不斷增強
    • 抑制因素
      • 與基因組設備相關的高成本
    • 機會
      • 基因序列分析與資料分析的技術進步
      • 政府加大力度和資助以促進研究活動
    • 任務
      • 與解釋遺傳訊息相關的複雜性
  • 市場區隔分析
    • 組成部分：高通量定序設備的不斷進步
    • 技術：準確、全面的基因組分析提高了次世代定序的普及度
    • 應用：增加對先進基因組測試的投資
    • 最終用途：先進基因組學在診斷實驗室中對遺傳疾病研究的重要性日益增加
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 基因組測試市場：依組成部分

  • 消耗品
  • 裝置
  • 軟體和服務

第7章 基因組測試市場：依技術分類

  • 微陣列
  • 次世代定序
  • 標靶定定序
  • 全基因組序列分析

第8章 基因組檢測市場：依應用分類

  • 癌症
  • 非癌症

第9章 基因組測試市場：依分銷管道分類

  • 離線
  • 線上

第 10 章 基因組測試市場：依最終用途

  • 診斷實驗室
  • 醫院/診所

第11章 南北美洲基因組檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太基因組檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東、非洲基因組檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Corn Health 為 10 萬個基因組計劃做準備
    • Illumina 推出先進的液態生物檢體檢測技術，可對固態腫瘤進行全面的基因組分析
    • 阿波羅在清奈開設基因組研究所，並計劃在 2023 年再開設三所
  • 戰略分析和建議

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-647F3A880B41

[199 Pages Report] The Genome Testing Market size was estimated at USD 17.57 billion in 2023 and expected to reach USD 19.76 billion in 2024, at a CAGR 13.21% to reach USD 41.90 billion by 2030.

Genome Testing, often referred to as whole genome sequencing (WGS), involves examining the complete sequence of DNA in an organism's genome at a single time. This comprehensive analysis covers all types of genetic variations, including insertions, deletions, single nucleotide polymorphisms (SNPs), copy number variations, and large structural changes. Growing emphasis on early disease detection & prevention, along with the increasing interest in ancestry and genealogy, boosts the significance of genome testing. However, the high cost associated with genomics equipment and the complexity of interpreting genetic information impact the market growth. Furthermore, the integration of AI and big data analytics for improved interpretation of genetic data is creating a potential opportunity for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 17.57 billion
Estimated Year [2024] USD 19.76 billion
Forecast Year [2030] USD 41.90 billion
CAGR (%) 13.21%

Regional Insights

In the Americas, particularly in the United States and Canada, the consumer need for genome testing is driven by a heightened awareness of personalized medication and a growing focus on preventive healthcare procedures. Customers in these regions exhibit a willingness to invest in health and wellness, supported by higher disposable income and substantial healthcare spending. The increasing prevalence of genetic disorders has catalyzed the demand for genome testing services. The European Union displays a diverse market for genome testing due to differences in healthcare systems, regulations, and consumer attitudes across member countries. Privacy concerns, ethical considerations, and regulatory frameworks such as the General Data Protection Regulation (GDPR) profoundly influence customer purchasing behavior. Emerging economies in the MEA show varying levels of demand for genome testing. The Middle East, with its well-funded healthcare systems in countries, is witnessing an increased interest in genome testing for personalized medicine. The Asia Pacific region, especially China, Japan, and India, exhibits a rapidly developing market for genome testing. China's investment in biotechnology has soared, as evidenced by its large-scale genome research projects and international collaborations.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Genome Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of genetic disorders and cancer across the globe
      • Growing emphasis on early disease detection & prevention
      • Increasing awareness of personalized medicine
    • Market Restraints
      • High cost associated with genomics equipment
    • Market Opportunities
      • Technological advancements in gene sequencing and data analysis
      • Rising government initiatives and fundings for boosting research activities
    • Market Challenges
      • Complexities associated with the interpreting genetic information
  • Market Segmentation Analysis
    • Component: Ongoing advancements in equipments for high-throughput sequencing
    • Technology: Increasing preference of next-generation sequencing due to its precise and comprehensive genomic analysis
    • Application: Increasing investment for advance genome testing across
    • End-use: Rising significance of advanced genomic in diagnostic laboratories for research associated with genetic diseases
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Genome Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Genome Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Cone Health Readies for 100,000 Person Genomics Project

Cone Health is on the brink of launching an expansive genomic testing initiative designed to enhance the health and longevity of individuals throughout the Piedmont Triad region. The program aims to harness the predictive power of genomics to identify individuals at risk for certain diseases, such as breast cancer and cardiac issues, thereby enabling early intervention and personalized healthcare. Cone Health has partnered with population genomics specialist, Helix, and envisages recruiting 100,000 healthy volunteers within five years for DNA sequencing via blood or saliva samples. [Published On: 2023-12-04]

Illumina Launches Advanced Liquid Biopsy Assay to Enable Comprehensive Genomic Profiling of Solid Tumors

Illumina Inc. has unveiled its latest innovation, the TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2), designed for the comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) using a noninvasive liquid biopsy approach. The TSO 500 ctDNA v2 presents a significant advancement for cancer research, offering a viable solution for genomic profiling when tissue samples are unattainable or enhancing the insights gained from traditional tissue-based tests. [Published On: 2023-11-01]

Apollo Opens Genomic Institute In Chennai, to Open Three More in 2023

Apollo Hospitals Group has inaugurated a Genomics Institute in Chennai to advance the study of genes and tackle genetic disorders. This marks the newest addition to their growing network with existing facilities in Mumbai and Delhi. By the end of 2023, Apollo is poised to enhance its genomic footprint with additional institutes launching in Hyderabad, Bangalore, and Ahmedabad. The Chennai Institute is set to offer comprehensive genomic services, including genetic evaluation, clinical diagnostics, obstetric genetics, and cancer genomics. These services are meticulously designed to provide patients with critical information for the management and prevention of genetic disorders. [Published On: 2023-04-25]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Genome Testing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Genome Testing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, 23andMe, Inc, Abbott Laboratories, Agilent Technologies, Inc., BGI Group, Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche, Ltd., Freenome Holdings, Inc., GeneDx, LLC, Genomic Testing Cooperative, Helix OpCo, LLC, Illumina, Inc., Merck KGaA, New England Biolabs, Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Takara Bio Inc, Thermo Fisher Scientific Inc., Ultima Genomics, Inc., and VWR International, LLC.

Market Segmentation & Coverage

This research report categorizes the Genome Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Consumables
    • Equipment
    • Software & Services
  • Technology
    • Microarrays
    • Next-Generation Sequencing
    • Targeted Sequencing
    • Whole Genome Sequencing
  • Application
    • Cancer
      • Brain Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Lung Cancer
      • Melanoma
      • Ovarian Cancer
      • Prostate Cancer
    • Non-cancer
      • Cardiovascular Diseases
      • Neurological Disorders
      • Tumors
  • Distribution Channel
    • Offline
    • Online
  • End-use
    • Diagnostic Laboratories
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of genetic disorders and cancer across the globe
      • 5.1.1.2. Growing emphasis on early disease detection & prevention
      • 5.1.1.3. Increasing awareness of personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with genomics equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in gene sequencing and data analysis
      • 5.1.3.2. Rising government initiatives and fundings for boosting research activities
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with the interpreting genetic information
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Ongoing advancements in equipments for high-throughput sequencing
    • 5.2.2. Technology: Increasing preference of next-generation sequencing due to its precise and comprehensive genomic analysis
    • 5.2.3. Application: Increasing investment for advance genome testing across
    • 5.2.4. End-use: Rising significance of advanced genomic in diagnostic laboratories for research associated with genetic diseases
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Genome Testing Market, by Component

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment
  • 6.4. Software & Services

7. Genome Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Microarrays
  • 7.3. Next-Generation Sequencing
  • 7.4. Targeted Sequencing
  • 7.5. Whole Genome Sequencing

8. Genome Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer
  • 8.3. Non-cancer

9. Genome Testing Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Genome Testing Market, by End-use

  • 10.1. Introduction
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals & Clinics

11. Americas Genome Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Genome Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Genome Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Cone Health Readies for 100,000 Person Genomics Project
    • 14.3.2. Illumina Launches Advanced Liquid Biopsy Assay to Enable Comprehensive Genomic Profiling of Solid Tumors
    • 14.3.3. Apollo Opens Genomic Institute In Chennai, to Open Three More in 2023
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. GENOME TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. GENOME TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOME TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GENOME TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. GENOME TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. GENOME TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOME TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOME TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL GENOME TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL GENOME TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL GENOME TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOME TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL GENOME TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL GENOME TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL GENOME TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL GENOME TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENOME TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL GENOME TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENOME TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL GENOME TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENOME TESTING MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL GENOME TESTING MARKET SIZE, BY BRAIN CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENOME TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL GENOME TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENOME TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL GENOME TESTING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENOME TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL GENOME TESTING MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENOME TESTING MARKET SIZE, BY MELANOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL GENOME TESTING MARKET SIZE, BY MELANOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENOME TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL GENOME TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENOME TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL GENOME TESTING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL GENOME TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL GENOME TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL GENOME TESTING MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL GENOME TESTING MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL GENOME TESTING MARKET SIZE, BY TUMORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL GENOME TESTING MARKET SIZE, BY TUMORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL GENOME TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL GENOME TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL GENOME TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL GENOME TESTING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL GENOME TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL GENOME TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS GENOME TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES GENOME TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC GENOME TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 310. TAIWAN GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. THAILAND GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 318. THAILAND GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 322. THAILAND GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 323. THAILAND GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 324. THAILAND GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 325. VIETNAM GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 326. VIETNAM GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 327. VIETNAM GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 328. VIETNAM GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 329. VIETNAM GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. VIETNAM GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. VIETNAM GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 332. VIETNAM GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 333. VIETNAM GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 334. VIETNAM GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 335. VIETNAM GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. VIETNAM GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. VIETNAM GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 338. VIETNAM GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 339. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 340. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 341. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 342. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 344. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 345. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 346. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 347. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 348. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 349. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 353. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 354. EUROPE, MIDDLE EAST & AFRICA GENOME TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 355. DENMARK GENOME TESTING MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 356. DENMARK GENOME TESTING MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 357. DENMARK GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 358. DENMARK GENOME TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 359. DENMARK GENOME TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 360. DENMARK GENOME TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 361. DENMARK GENOME TESTING MARKET SIZE, BY CANCER, 2018-2023 (USD MILLION)
  • TABLE 362. DENMARK GENOME TESTING MARKET SIZE, BY CANCER, 2024-2030 (USD MILLION)
  • TABLE 363. DENMARK GENOME TESTING MARKET SIZE, BY NON-CANCER, 2018-2023 (USD MILLION)
  • TABLE 364. DENMARK GENOME TESTING MARKET SIZE, BY NON-CANCER, 2024-2030 (USD MILLION)
  • TABLE 365. DENMARK GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 366. DENMARK GENOME TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 367. DENMARK GENOME TESTING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 368. DENMARK